Please assess the completion status of the following clinical trial:

Trial Title: Syncardia 50cc TAH-t as a Bridge to Transplant

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria (Primary Pediatric and Adult Arms):~* At imminent risk of death from biventricular heart failure~* Aged 10 - 18 years (pediatric); 19 - 75 years (adults) at time of implant~* With two functional atrioventricular (A-V) valves~* With Body Surface Area (BSA) of 1.2 through 1.85m2~* With adequate sternum to T10 distance OR Adequate room in chest as determined by 3-D imaging assessment or by other standard clinical assessments~Exclusion Criteria:~* Patients who are not cardiac transplant-eligible~* Cardiac transplant-eligible patients~  * Who cannot be adequately anticoagulated on the TAH-t~ * With insufficient space in the chest~ * Who are on extracorporeal membrane oxygenation (ECMO) support \> 3 days~* Patients who are being supported by an investigational device at the time of evaluation for a 50cc TAH-t~* Patients who have required cardiopulmonary resuscitation (CPR) for \> 30 minutes within 14 days prior to proposed implant~* Patients who have experienced a stroke within 30 days prior to proposed implant~* Patients who are dialysis-dependent at time of proposed implant~Inclusion Criteria, Secondary Arm (pediatric and adult patients)~* Not eligible for Primary Arm~* At imminent risk of death from biventricular heart failure~* With Body Surface Area (BSA) of 1.2 through 1.85m2~* With adequate sternum to T10 distance OR Adequate room in chest as determined by 3-D imaging assessment or by other standard clinical assessments~Exclusion Criteria, Secondary Arm:~* Patients who are not cardiac transplant-eligible~* Cardiac transplant-eligible patients~  * Who cannot be adequately anticoagulated on the TAH-t~ * With insufficient space in the chest~* Patients who are being supported by an investigational device at the time of evaluation for a 50cc TAH-t

- Gender: ALL
- Minimum Age: 10 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Primary Pediatric Arm (Type: EXPERIMENTAL): Cardiac transplant-eligible pediatric patients at imminent risk of death from biventricular failure who are 10 - 18 years old at time of TAH-t implant. The intervention is implantation with the 50cc temporary Total Artificial Heart as a bridge to transplantation.
- Primary Adult Arm (Type: EXPERIMENTAL): Cardiac transplant-eligible adult patients at imminent risk of death from biventricular failure who are 19 - 75 years old at time of TAH-t implant. The intervention is implantation with the 50cc temporary Total Artificial Heart as a bridge to transplantation.
- Secondary Arm (Type: EXPERIMENTAL): Cardiac transplant-eligible pediatric and adult patients at imminent risk of death from biventricular failure who do not meet enrollment criteria for a Primary Arm, but meet less restrictive enrollment criteria for the Secondary Arm. The intervention is implantation with the 50cc temporary Total Artificial Heart as a bridge to transplantation.

Based on this trial design, predict the completion outcome and termination type (if applicable).

Answer: outcome: terminate
termination_type: regulatory/approval